drugset / Trial / NCT07602257
Investigating a Personalized Approach to Anti-Platelet Therapy
RandomizedSequentialSingle-blindPrevention
Summary
RAPID PREVENT aims to identify if a personalized (targeted) anti-platelet strategy will reduce bleeding events when compared to the current standard anti-platelet therapy.
Timeline
- Start
- 2026-10-01
- Primary completion
- 2029-12-28
- Completion
- 2029-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | — |
| Subject | Clopidogrel | Small molecule | — | — |
| Subject | Ticagrelor | Small molecule | — | — |
Indications
No indication recorded.